UBE2C Human shRNA Plasmid Kit (Locus ID 11065)

Specifications

Product Data
Product Name	UBE2C Human shRNA Plasmid Kit (Locus ID 11065)
Locus ID	11065
UniProt ID	O00762
Synonyms	dJ447F3.2; UBCH10
Vector	pGFP-C-shLenti
Format	Lentiviral plasmids
Kit Components	UBE2C - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 11065). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free.
RefSeq	NM_001281741, NM_001281742, NM_007019, NM_181799, NM_181800, NM_181801, NM_181802, NM_181803, NR_104036, NR_104037, NM_181801.1, NM_181801.2, NM_181801.3, NM_007019.1, NM_007019.2, NM_007019.3, NM_181800.1, NM_181800.2, NM_181803.1, NM_181799.1, NM_181799.2, NM_001281742.1, NM_001281741.1, NM_181802.1, BC007656, BC007656.2, BC050736, BC016292, BC028161, BC032677, BM556795, BM747513, NM_007019.4, NM_181799.3, NM_181800.3
Summary	The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, ubiquitin-conjugating enzymes, and ubiquitin-protein ligases. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein is required for the destruction of mitotic cyclins and for cell cycle progression, and may be involved in cancer progression. Multiple transcript variants encoding different isoforms have been found for this gene. Pseudogenes of this gene have been defined on chromosomes 4, 14, 15, 18, and 19. [provided by RefSeq, Aug 2013]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.